Oral carcinoma (OC) represents a significant health problem in the U.S. Standard therapies, including surgery, radiation therapy, and chemotherapy have not significantly changed the outcome of OC during the last decades. To improve therapy of OC, it is necessary to understand the biology governing selection, death and survival of OC cells. Although immune surveillance is expected to protect against cancer, cancer development occurs in apparently immunocompetent hosts. Our recent studies have demonstrated that immune effector cells, such as natural killer (NK) cells and cytotoxic T lymphocytes (CTLs), express a variety of the TNF family ligands, while cancer cells express the corresponding receptors. These complementary pairs of receptor-ligands interact and mediate apoptosis in cancer cells. We have discovered that this killing cannot be induced by the engagement of a single ligand-receptor pair. It is only inducible by simultaneous interactions of at least three different ligand-receptor. The apoptotic pathway can be completely inhibited by interference with the engagement of a single ligand-receptor pair. OC cells, like other cancer cells, express a variety ro the TNF family receptors and yet are relatively resistant to apoptosis mediated by their ligation. This apoptotic pathway can be completely inhibited by interference with the engagement of a single ligand-receptor pair. OC cells, like other cancer cells, express a variety of the TNF family receptors and yet are relatively resistant to apoptosis mediated by their ligation. Furthermore, peripheral blood cells of OC patients show impaired ability to induced apoptosis in OC targets. Based on these novel observations, we hypothesize that OC cells are resistant to control by the immune system, in par, because they have been selected in vivo via the TNF family ligands for the defective TNF family receptors. Also, we postulate that there may be similar defects in the TNF family ligands on immune effector cells in OC patients.. Either of these abnormalities could interfere with effective host defense against transformed cells and thereby facilitate or enable the development of OC. To test these hypotheses, we propose to show that apoptosis of OC cells is a universal mechanism which can be induced by a variety of immune cells through simultaneous engagement of at least three TNF family ligands (Aim 1). Possible abnormalities of the TNF family receptors on OC cells as well as ligands on immune cells will be investigated by assessing levels of their cell membrane expression, secretion of soluble forms, and the ability to signal or mediate apoptosis, respectively (Aims 2 and 3). Also, various immune interventions will be tested in vitro in order to correct abnormalities of the TNF family receptors on OC cells and/or their ligands on immune cells of OC patients and thereby render OC cells susceptible to apoptosis (Aim 4). This study will determine the role of the TNF family receptors and ligands in escape of OC from immune control and might lead to the development of novel strategies for determining prognosis or improving therapy of OC.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Comprehensive Center (P60)
Project #
3P60DE013059-02S1
Application #
6396948
Study Section
Project Start
2000-08-01
Project End
2001-07-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Sobo-Vujanovic, Andrea; Munich, Stephan; Vujanovic, Nikola L (2014) Dendritic-cell exosomes cross-present Toll-like receptor-ligands and activate bystander dendritic cells. Cell Immunol 289:119-27
Baskic, Dejan; Vujanovic, Lazar; Arsenijevic, Nebojsa et al. (2013) Suppression of natural killer-cell and dendritic-cell apoptotic tumoricidal activity in patients with head and neck cancer. Head Neck 35:388-98
Wan, Xiao Chloe; Egloff, Ann Marie; Johnson, Jonas (2012) Histological assessment of cervical lymph node identifies patients with head and neck squamous cell carcinoma (HNSCC): who would benefit from chemoradiation after surgery? Laryngoscope 122:2712-22
Zhong, Shilong; Nukui, Tomoko; Buch, Shama et al. (2011) Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent. Cancer Epidemiol Biomarkers Prev 20:2429-37
Ge, Lisheng; Baskic, Dejan; Basse, Per et al. (2009) Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer. Cancer Epidemiol Biomarkers Prev 18:2913-22
Martin, Christa Lese; Reshmi, Shalini C; Ried, Thomas et al. (2008) Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. Oral Oncol 44:369-82
Buch, Shama C; Nazar-Stewart, Valle; Weissfeld, Joel L et al. (2008) Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes. Head Neck 30:1139-47
White, Jason S; Weissfeld, Joel L; Ragin, Camille C R et al. (2007) The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol 43:701-12
Xu, Jun; Chakrabarti, Ayan K; Tan, Jennifer L et al. (2007) Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk. Blood 109:3333-41
Makarenkova, Valeria; Chakrabarti, Ayan K; Liberatore, Jennifer A et al. (2005) Dendritic cells and natural killer cells interact via multiple TNF family molecules. J Leukoc Biol 77:408-13

Showing the most recent 10 out of 39 publications